Subscribe To
PULM / Pulmatrix (PULM) Stock: 1-For-20 Reverse Split Goes Into Effect
PULM News
By PRNewsWire
May 24, 2023
Pulmatrix Selected to Present at the Annual Biotechnology Innovation Organization (BIO) International Convention
Presentation will showcase Company's patented iSPERSE⢠technology and positive topline results from Phase 1 study of PUR3100 for acute migraine LEXI more_horizontal
By PRNewsWire
January 23, 2023
Pulmatrix to Present Data on PUR1800 at the Annual Meeting of the American Academy of Allergy, Asthma and Immunology
LEXINGTON, Mass. , Jan. 23, 2023 /PRNewswire/ -- Pulmatrix, Inc. (NASDAQ: PULM), a clinical-stage biopharmaceutical company developing innovative inha more_horizontal
By Pulse2
March 1, 2022
Pulmatrix (PULM) Stock: 1-For-20 Reverse Split Goes Into Effect
A 1-for-20 reverse split of Pulmatrix Inc (NASDAQ: PULM) stock has gone into effect. These are the details. more_horizontal
By Pulse2
March 1, 2022
Pulmatrix (PULM) Stock: 1-For-20 Reverse Split Goes Into Effect
A 1-for-20 reverse split of Pulmatrix Inc (NASDAQ: PULM) stock has gone into effect. These are the details. more_horizontal
By Pulse2
March 1, 2022
Pulmatrix (PULM) Stock: 1-For-20 Reverse Split Goes Into Effect
A 1-for-20 reverse split of Pulmatrix Inc (NASDAQ: PULM) stock has gone into effect. These are the details. more_horizontal